Morning Movers 09/01: (LQDT) (CIEN) (UTIW) (MOV) Higher; (CWTR) (GEF) (SAI) (DCTH) Lower
Tweet
Share
E-mail
Get Alerts LQDT Hot Sheet
Join SI Premium – FREE
Liquidity Services, Inc. (Nasdaq: LQDT) 25.8% HIGHER; has agreed to acquire the consumer goods remarketing business of Jacobs Trading Company (Jacobs Trading) for $140 million plus potential performance-based consideration.
Ciena Corporation (NASDAQ: CIEN) 19.3% HIGHER; reported Q3 EPS of $0.08, $0.16 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $435.3 million versus the consensus estimate of $443.25 million. Sees Q4 sales of $440-$460 million, which compares to the Street estimate of $474.5 million.
UTI Worldwide, Inc. (NASDAQ: UTIW) 13.7% HIGHER; reported Q2 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.25 billion.
Coldwater Creek, Inc. (NASDAQ: CWTR) 12.5% LOWER; reported Q2 EPS of ($0.27), versus ($0.16) reported last year. Revenue for the quarter came in at $181.4 million versus the consensus estimate of $206.46 million.
Greif Inc. (NYSE: GEF) 12.3% LOWER; reported Q3 adjusted EPS of $1.18, $0.15 worse than the analyst estimate of $1.33. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.11 billion. Greif Inc. sees FY2011 EPS of $4.15-$4.30, versus the consensus of $4.73.
Saic, Inc. (NYSE: SAI) 12.1% LOWER; reported Q2 EPS of $0.32, $0.03 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.77 billion. Sees FY12 EPS from continuing operations of $1.30-$1.40, which compares to the Street estimate of $1.43. See sales of $10.6-$11 billion, vs. consensus of $11.2 billion.
Delcath Systems, Inc. (Nasdaq: DCTH) 10.9% LOWER; reported top-line results from the metastatic colorectal (adenocarcinoma) cohort of the Phase II clinical trial of the Delcath chemosaturation system with melphalan in the treatment of patients with unresectable liver cancer.
Methode Electronics (NYSE: MEI) 10.3% LOWER; reported Q1 GAAP EPS of $0.04, which may not compare with the analyst estimate of $0.10. Revenue for the quarter came in at $110.8 million versus the consensus estimate of $110.3 million.
Movado Group, Inc. (NYSE: MOV) 10.3% HIGHER; reported Q2 EPS of $0.16, $0.10 better than the analyst estimate of $0.06. Revenue for the quarter came in at $113.2 million versus the consensus estimate of $96.6 million.
Shuffle Master, Inc. (NASDAQ: SHFL) 10.3% HIGHER; reported Q3 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $58.3 million versus the consensus estimate of $58.14 million.
Stereotaxis (Nasdaq: STXS) 10.2% HIGHER; continuing higher after flirting with the $1 level for some time. Since breaking through resistance at this level last week, shares are now up 44.3%.
Brightpoint (NASDAQ: CELL) 7.4% HIGHER; Citi upgraded the stock from Hold to Buy.
Pier 1 Imports, Inc. (NYSE: PIR) 6.7% HIGHER; reports total sales for the second-quarter of 2011 were $340 million, up 9.7 percent from the same period last year.ens Same-store sales rose 10.8 percent. Sees Q211 EPS of 14 cents per share, versus the consensus of 13 cents per share.
Ciena Corporation (NASDAQ: CIEN) 19.3% HIGHER; reported Q3 EPS of $0.08, $0.16 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $435.3 million versus the consensus estimate of $443.25 million. Sees Q4 sales of $440-$460 million, which compares to the Street estimate of $474.5 million.
UTI Worldwide, Inc. (NASDAQ: UTIW) 13.7% HIGHER; reported Q2 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.25 billion.
Coldwater Creek, Inc. (NASDAQ: CWTR) 12.5% LOWER; reported Q2 EPS of ($0.27), versus ($0.16) reported last year. Revenue for the quarter came in at $181.4 million versus the consensus estimate of $206.46 million.
Greif Inc. (NYSE: GEF) 12.3% LOWER; reported Q3 adjusted EPS of $1.18, $0.15 worse than the analyst estimate of $1.33. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.11 billion. Greif Inc. sees FY2011 EPS of $4.15-$4.30, versus the consensus of $4.73.
Saic, Inc. (NYSE: SAI) 12.1% LOWER; reported Q2 EPS of $0.32, $0.03 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.77 billion. Sees FY12 EPS from continuing operations of $1.30-$1.40, which compares to the Street estimate of $1.43. See sales of $10.6-$11 billion, vs. consensus of $11.2 billion.
Delcath Systems, Inc. (Nasdaq: DCTH) 10.9% LOWER; reported top-line results from the metastatic colorectal (adenocarcinoma) cohort of the Phase II clinical trial of the Delcath chemosaturation system with melphalan in the treatment of patients with unresectable liver cancer.
Methode Electronics (NYSE: MEI) 10.3% LOWER; reported Q1 GAAP EPS of $0.04, which may not compare with the analyst estimate of $0.10. Revenue for the quarter came in at $110.8 million versus the consensus estimate of $110.3 million.
Movado Group, Inc. (NYSE: MOV) 10.3% HIGHER; reported Q2 EPS of $0.16, $0.10 better than the analyst estimate of $0.06. Revenue for the quarter came in at $113.2 million versus the consensus estimate of $96.6 million.
Shuffle Master, Inc. (NASDAQ: SHFL) 10.3% HIGHER; reported Q3 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $58.3 million versus the consensus estimate of $58.14 million.
Stereotaxis (Nasdaq: STXS) 10.2% HIGHER; continuing higher after flirting with the $1 level for some time. Since breaking through resistance at this level last week, shares are now up 44.3%.
Brightpoint (NASDAQ: CELL) 7.4% HIGHER; Citi upgraded the stock from Hold to Buy.
Pier 1 Imports, Inc. (NYSE: PIR) 6.7% HIGHER; reports total sales for the second-quarter of 2011 were $340 million, up 9.7 percent from the same period last year.ens Same-store sales rose 10.8 percent. Sees Q211 EPS of 14 cents per share, versus the consensus of 13 cents per share.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Citi raises Deere price target to $650, keeps Neutral rating
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Citi, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
